RhoA/ROCK-dependent moesin phosphorylation regulates AGE-induced endothelial cellular response

Cardiovascular Diabetology

Volumn 11, Issue , 2012, Pages

  Wang, Jiping ^a   Liu, Hongxia ^a   Chen, Bo ^a   Li, Qiang ^a   Huang, Xuliang ^a   Wang, Liqun ^a   Guo, Xiaohua ^a   Huang, Qiaobing ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Advanced glycation end products (ages); Moesin; Rhoa rock pathway; Vascular permeability

Indexed keywords

ADENOVIRUS VECTOR; ADVANCED GLYCATION END PRODUCT; F ACTIN; HUMAN SERUM ALBUMIN; MOESIN; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; ACTIN; ACTIN BINDING PROTEIN; ADVANCED GLYCATION END PRODUCTS HUMAN SERUM ALBUMIN; ADVANCED GLYCATION END PRODUCTS-HUMAN SERUM ALBUMIN; PROTEIN KINASE INHIBITOR; RHOA PROTEIN, HUMAN; SERUM ALBUMIN;

ARTICLE; DIABETES MELLITUS; DOWN REGULATION; ENDOTHELIUM CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LUMINESCENCE; MUTANT; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; BINDING SITE; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENE SILENCING; GENETICS; METABOLISM; MUTATION; PATHOLOGY; PERMEABILITY; PHOSPHORYLATION; STRESS FIBER; TIME; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING;

ACTINS; BINDING SITES; BLOTTING, WESTERN; CELLS, CULTURED; ENDOTHELIAL CELLS; GENE KNOCKDOWN TECHNIQUES; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IMMUNOPRECIPITATION; MICROFILAMENT PROTEINS; MUTATION; PERMEABILITY; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; RHO-ASSOCIATED KINASES; RHOA GTP-BINDING PROTEIN; SERUM ALBUMIN; STRESS FIBERS; TIME FACTORS; TRANSFECTION;

EID: 84855780092     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-11-7     Document Type: Article

References (53)

1. Vlassara H, Uribarri J, Cai W, Striker G. Advanced glycation end product homeostasis: exogenous oxidants and innate defenses. Ann NY Acad Sci 2008, 1126:46-52. 10.1196/annals.1433.055, 18448795.
2. Goldin A, Beckman JA, Schmidt AM, Creager MA. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 2006, 114:597-605. 10.1161/CIRCULATIONAHA.106.621854, 16894049.
3. Li R, McCourt P, Schledzewski K, Goerdt S, Moldenhauer G, Liu X, Smedsrød B, Sørensen KK. Endocytosis of advanced glycation end-products in bovine choriocapillaris endothelial cells. Microcirculation 2009, 4:1-16.
4. Gao X, Zhang H, Schmidt AM, Zhang C. AGE/RAGE produces endothelial dysfunction in coronary arterioles in type 2 diabetic mice. Am J Physiol Heart Circ Physiol 2008, 295:H491-H498. 10.1152/ajpheart.00464.2008, 2519223, 18539754.
5. Peppa M, Uribarri J, Vlassara H. Glucose, advanced glycation end products, and diabetes complications: what is new and what works. Clinical Diabetes 2003, 21:186-1873.
6. Rahman S, Rahman T, Ismail AA, Rashid AR. Diabetes-associated macrovasculopathy: pathophysiology and pathogenesis. Diabetes Obes Metab 2007, 9:767-780. 10.1111/j.1463-1326.2006.00655.x, 17924861.
7. Yamagishi S, Nakamura K, Imaizumi T. Advanced glycation end products (AGEs) and diabetic vascular complications. Curr Diabetes Rev 2005, 1:93-106. 10.2174/1573399052952631, 18220586.
8. Bu DX, Rai V, Shen X, Rosario R, Lu Y, D'Agati V, Yan SF, Friedman RA, Nuglozeh E, Schmidt AM. Activation of the ROCK1 branch of the transforming growth factor-beta pathway contributes to RAGE-dependent acceleration of atherosclerosis in diabetic ApoE-null mice. Circ Res 2010, 106:1040-1051. 10.1161/CIRCRESAHA.109.201103, 2848909, 20133903.
9. Tan KC, Shiu SW, Chow WS, Leng L, Bucala R, Betteridge DJ. Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes. Diabetologia 2006, 49:2756-2762. 10.1007/s00125-006-0394-1, 16969649.
10. Yoon YW, Kang TS, Lee BK, Chang W, Hwang KC, Rhee JH, Min PK, Hong BK, Rim SJ, Kwon HM. Pathobiological role of advanced glycation endproducts via mitogen-activated protein kinase dependent pathway in the diabetic vasculopathy. Exp Mol Med 2008, 40:398-406. 10.3858/emm.2008.40.4.398, 2679265, 18779652.
11. Torreggiani M, Liu H, Wu J, Zheng F, Cai W, Striker G, Vlassara H. Advanced glycation end product receptor-1 transgenic mice are resistant to inflammation, oxidative stress, and post-injury intimal hyperplasia. Am J Pathol 2009, 175:1722-1732. 10.2353/ajpath.2009.090138, 2751567, 19779136.
12. Yuan SY, Breslin JW, Perrin R, Gaudreault N, Guo M, Kargozaran H, Wu MH. Microvascular permeability in diabetes and insulin resistance. Microcirculation 2007, 14:363-373. 10.1080/10739680701283091, 17613808.
13. Soro-Paavonen A, Zhang WZ, Venardos K, Coughlan MT, Harris E, Tong DC, Brasacchio D, Paavonen K, Chin-Dusting J, Cooper ME, Kaye D, Thomas MC, Forbes JM. Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthase. J Hypertens 2010, 28:780-788. 10.1097/HJH.0b013e328335043e, 20186099.
14. Hirose A, Tanikawa T, Mori H, Okada Y, Tanaka Y. Advanced glycation end products increase endothelial permeability through the RAGE/Rho signaling pathway. FEBS Lett 2010, 584:61-66. 10.1016/j.febslet.2009.11.082, 19944695.
15. Wang Z, Guo X, Liu X, Wang J, Wang L, Huang Q. The morphological changes of vascular endothelial cadherin in human umbilical vein endothelial cells induced by advanced glycation end products. Chin J Arterioscler 2008, 16:505-509.
16. Birukova AA, Smurova K, Birukov KG, Usatyuk P, Liu F, Kaibuchi K, Ricks-Cord A, Natarajan V, Alieva I, Garcia JG, Verin AD. Microtubule disassembly induces cytoskeletal remodeling and lung vascular barrier dysfunction: role of Rho-dependent mechanisms. J Cell Physiol 2004, 201:55-70. 10.1002/jcp.20055, 15281089.
17. Gorovoy M, Niu J, Bernard O, Profirovic J, Minshall R, Neamu R, Voyno-Yasenetskaya T. LIM kinase 1 coordinates microtubule stability and actin polymerization in human endothelial cells. J Biol Chem 2005, 280:26533-26542. 10.1074/jbc.M502921200, 1403832, 15897190.
18. Van Nieuw Amerongen GP, Beckers CM, Achekar ID, Zeeman S, Musters RJ, van Hinsbergh VW. Involvement of Rho kinase in endothelial barrier maintenance. Arterioscler Thromb Vasc Biol 2007, 27:2332-2339. 10.1161/ATVBAHA.107.152322, 17761936.
19. Van Nieuw Amerongen GP, Musters RJ, Eringa EC, Sipkema P, van Hinsbergh VW. Thrombin-induced endothelial barrier disruption in intact microvessels: role of RhoA/Rho kinase-myosin phosphatase axis. Am J Physiol Cell Physiol 2008, 294:C1234-C1241. 10.1152/ajpcell.00551.2007, 18353893.
20. Guo X, Wang L, Chen B, Li Q, Wang J, Zhao M, Wu W, Zhu P, Huang X, Huang Q. ERM protein Moesin is phosphorylated by advanced glycation end products and modulate vascular permeability. Am J Physiol Heart Circ Physiol 2009, 297:H238-H246. 10.1152/ajpheart.00196.2009, 19395553.
21. Mangeat P, Roy C, Martin M. ERM proteins in cell adhesion and membrane dynamics. Trends Cell Biol 1999, 9:187-192. 10.1016/S0962-8924(99)01544-5, 10322453.
22. Niggli V, Rossy JR. Ezrin/radixin/moesin: versatile controllers of signaling molecules and of the cortical skeleton. Int J Biochem Cell Biol 2008, 40:344-349. 10.1016/j.biocel.2007.02.012, 17419089.
23. Matsui T, Maeda M, Doi Y, Yonemura S, Amano M, Kaibuchi K, Tsukita S, Tsukita S. Rho-kinase phosphorylates COOH-terminal threonines of ezrin/radixin/moesin (ERM) proteins and regulates their head-to-tail association. J Cell Biol 1998, 140:647-657. 10.1083/jcb.140.3.647, 2140160, 9456324.
24. Berryman M, Franck Z, Bretscher A. Ezrin is concentrated in the apical microvilli of a wide variety of epithelial cells whereas moesin is found primarily in endothelial cells. J Cell Sci 1993, 105:1025-1043.
25. Li Q, Liu H, Du J, Chen B, Li Q, Guo X, Huang X, Huang Q. Advanced glycation end products induce moesin phosphorylation in murine brain endothelium. Brain Res 2011, 1373:1-10.
26. Hou FF, Boyce J, Chertow GM, Kay J, Owen WF. Aminoguanidine inhibits advanced glycation end products formation on beta2-microglobulin. J Am Soc Nephrol 1998, 9:277-283.
27. Hou FF, Miyata T, Boyce J, Yuan Q, Chertow GM, Kay J, Schmidt AM, Owen WF. Beta(2)-Microglobulin modified with advanced glycation end products delays monocyte apoptosis. Kidney Int 2001, 59:990-1002. 10.1046/j.1523-1755.2001.059003990.x, 11231354.
28. Stein GH, St Clair JA. Human microvascular endothelial cells: coordinate induction of morphologic differentiation and twofold extension of life span. In Vitro Cell Dev Bio 1998, 24:381-387.
29. Takagi M, Nishioka M, Kakihara H, Kitabayashi M, Inoue H, Kawakami B, Oka M, Imanaka T. Characterization of DNA polymerase from Pyrococcus sp. strain KOD1 and its application to PCR. Appl Environ Microbio 1997, 63:4504-4510.
30. Hashimoto H, Nishioka M, Fujiwara S, Takagi M, Imanaka T, Inoue T, Kai Y. Crystal structure of DNA polymerase from hyperthermophilic archaeon Pyrococcus kodakaraensis KOD1. J Mol Biol 2001, 306:469-77. 10.1006/jmbi.2000.4403, 11178906.
31. Tinsley JH, Wu MH, Ma W, Taulman AC, Yuan SY. Activated neutrophils induce hyperpermeability and phosphorylation of adherens junction proteins in coronary venular endothelial cells. J Biol Chem 1999, 274:24930-24934. 10.1074/jbc.274.35.24930, 10455168.
32. Guo X, Huang Q, Chen B, Wang S, Hou F, Fu N. Mechanism of advanced glycation end products-induced hyperpermeability in endothelial cells. Acta Physiol Sino 2005, 57:205-210.
33. Breitenlechner C, Gassel M, Hidaka H, Kinzel V, Huber R, Engh RA, Bossemeyer D. Protein kinase A in complex with Rho-kinase inhibitors Y-27632, Fasudil, and H-1152P: structural basis of selectivity. Structure 2003, 1:1595-1607.
34. Sasaki Y, Suzuki M, Hidaka H. The novel and specific Rho-kinase inhibitor (S)-(+)-2-methyl-1-[(4-methyl- 5-isoquinoline)sulfonyl]-homopiperazine as a probing molecule for Rho-kinase-involved pathway. Pharmacol Ther 2002, 93:225-232. 10.1016/S0163-7258(02)00191-2, 12191614.
35. Shimada H, Rajagopalan LE. Rho kinase-2 activation in human endothelial cells drives lysophosphatidic acid-mediated expression of cell adhesion molecules via NF-kappaB p65. J Biol Chem 2010, 285:12536-12542. 10.1074/jbc.M109.099630, 20164172.
36. Komarova Y, Malik AB. Regulation of endothelial permeability via paracellular and transcellular transport pathways. Annu Rev Physiol 2010, 72:463-493. 10.1146/annurev-physiol-021909-135833, 20148685.
37. Sun H, Breslin JW, Zhu J, Yuan SY, Wu MH. Rho and ROCK signaling in VEGF-induced microvascular endothelial hyperpermeability. Microcirculation 2006, 13:237-47. 10.1080/10739680600556944, 16627366.
38. You J, Peng W, Lin X, Huang QL, Lin JY. PLC/CAMK IV-NF-kappaB involved in the receptor for advanced glycation end products mediated signaling pathway in human endothelial cells. Mol Cell Endocrinol 2010, 320:111-117. 10.1016/j.mce.2010.01.036, 20171262.
39. Bogatcheva NV, Adyshev D, Mambetsariev B, Moldobaeva N, Verin AD. Involvement of microtubules, p38, and Rho kinases pathway in 2-methoxyestradiol-induced lung vascular barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 2007, 292:487-499.
40. Garcia MC, Ray DM, Lackford B, Rubino M, Olden K, Roberts JD. Arachidonic acid stimulates cell adhesion through a novel p38 MAPK-RhoA signaling pathway that involves heat shock protein 27. J Biol Chem 2009, 284:20936-20945. 10.1074/jbc.M109.020271, 2742859, 19506078.
41. Kamaraju AK, Roberts AB. Role of Rho/ROCK and p38 MAP kinase pathways in transforming growth factor-beta-mediated Smad-dependent growth inhibition of human breast carcinoma cells in vivo. J Biol Chem 2005, 280:1024-1036.
42. Marinissen MJ, Chiariello M, Gutkind JS. Regulation of gene expression by the small GTPase Rho through the ERK6 (p38 gamma) MAP kinase pathway. Genes 2001, 15:535-553.
43. Totsukawa G, Yamakita Y, Yamashiro S, Hartshorne DJ, Sasaki Y, Matsumura F. Distinct roles of ROCK (Rho-kinase) and MLCK in spatial regulation of MLC phosphorylation for assembly of stress fibers and focal adhesions in 3T3 fibroblasts. J Cell Biol 2000, 150:797-806. 10.1083/jcb.150.4.797, 2175273, 10953004.
44. Essler M, Amano M, Kruse HJ, Kaibuchi K, Weber PC, Aepfelbacher M. Thrombin inactivates myosin light chain phosphatase via Rho and its target Rho kinase in human endothelial cells. J Biol Chem 1998, 273:21867-21874. 10.1074/jbc.273.34.21867, 9705325.
45. Essler M, Retzer M, Bauer M, Heemskerk JW, Aepfelbacher M, Siess W. Mildly oxidized low density lipoprotein induces contraction of human endothelial cells through activation of Rho/Rho kinase and inhibition of myosin light chain phosphatase. J Biol Chem 1999, 274:30361-30364. 10.1074/jbc.274.43.30361, 10521411.
46. Shen Q, Wu MH, Yuan SY. Endothelial contractile cytoskeleton and microvascular permeability. Cell Health Cytoskelet 2009, 1:43-50.
47. Prasain N, Stevens T. The actin cytoskeleton in endothelial cell phenotypes. Microvasc Res 2009, 77:53-63. 10.1016/j.mvr.2008.09.012, 2700738, 19028505.
48. Bogatcheva NV, Zemskova MA, Gorshkov BA, Kim KM, Daglis GA, Poirier C, Verin AD. ERM are Phosphorylated in Response to 2-methoxyestradiol and Modulate Endothelial Hyperpermeability. Am J Respir Cell Mol Biol 2011,
49. Hébert M, Potin S, Sebbagh M, Bertoglio J, Bréard J, Hamelin J. Rho-ROCK-dependent ezrin-radixin-moesin phosphorylation regulates Fas-mediated apoptosis in Jurkat cells. J Immunol 2008, 181:5963-5973.
50. Jaleel M, Nichols RJ, Deak M, Campbell DG, Gillardon F, Knebel A, Alessi DR. LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity. Biochem J 2007, 405:307-317. 10.1042/BJ20070209, 1904520, 17447891.
51. Coffey GP, Rajapaksa R, Liu R, Sharpe O, Kuo CC, Krauss SW, Sagi Y, Davis RE, Staudt LM, Sharman JP, Robinson WH, Levy S. Engagement of CD81 induces ezrin tyrosine phosphorylation and its cellular redistribution with filamentous actin. J Cell Sci 2009, 122:3137-3144. 10.1242/jcs.045658, 2729262, 19654214.
52. Koss M, Pfeiffer GR, Wang Y, Thomas ST, Yerukhimovich M, Gaarde WA, Doerschuk CM, Wang Q. Ezrin/radixin/moesin proteins are phosphorylated by TNF-alpha and modulate permeability increases in human pulmonary microvascular endothelial cells. J Immunol 2006, 176:1218-1227.
53. Zhou R, Cao X, Watson C, Miao Y, Guo Z, Forte JG, Yao X. Characterization of protein kinase A-mediated phosphorylation of ezrin in gastric parietal cell activation. J Biol Chem 2003, 37:35651-35659.